Company Profiles

driven by the PitchBook Platform

Agilome

2016 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
2 INVESTORS
Description

Developer of a technology specializing in graphene enhanced genomics sequencing. The company leads commercialization of technologies to support genomic medicine.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Primary Office
3344 North Torrey Pines
Court Plaza Level
La Jolla, CA 92037
United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Agilome’s full profile, request a free trial.

Agilome Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Agilome Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
EvoNexus Accelerator/Incubator 000 0000 000000 0
FusionX Ventures Venture Capital Minority 000 0000 000000 0

You’re viewing 2 of 2 investors.

Agilome Executive Team (1)

Name Title Board
Seat
Contact
Info
Gina Costa Ph.D Chief Scientific Officer

You’re viewing 1 of 1 executives.

Agilome Board Members (1)

Name Representing Role Since Contact
Info
Kirk Malloy Ph.D Agilome Chairman 000 0000

You’re viewing 1 of 1 board members.